Published in World J Gastroenterol on October 28, 2006
Evidence-based current surgical practice: calculous gallbladder disease. J Gastrointest Surg (2012) 1.88
Acute Bacterial Cholangitis. Viszeralmedizin (2015) 0.90
Management of acute cholangitis. Gastroenterol Hepatol (N Y) (2011) 0.84
What are the risk factors for acute suppurative cholangitis caused by common bile duct stones? Gut Liver (2010) 0.83
Possible mortality reduction by endoscopic sphincterotomy during endoscopic retrograde cholangiopancreatography: a population-based case-control study. Surg Endosc (2011) 0.76
Role of radial endosonography in the diagnosis of acute cholangitis. Dig Dis Sci (2011) 0.76
Risk factors of organ failure in cholangitis with bacteriobilia. World J Gastroenterol (2015) 0.75
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg (1985) 2.66
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Acute cholangitis. Ann Surg (1980) 2.24
Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg (1996) 2.20
The benefits of endoscopic nasobiliary drainage without sphincterotomy for acute cholangitis. Am J Gastroenterol (1998) 1.78
Does the addition of endoscopic sphincterotomy to stent insertion improve drainage of the bile duct in acute suppurative cholangitis? Gastrointest Endosc (2003) 1.64
Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg (1986) 1.53
Urgent endoscopic drainage for acute suppurative cholangitis. Lancet (1989) 1.48
Factors in management of acute cholangitis. Ann Surg (1982) 1.41
Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis. Endoscopy (2005) 1.39
Treatment of acute cholangitis due to choledocholithiasis in elderly and younger patients. Arch Surg (1997) 1.33
Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases. J Gastroenterol Hepatol (2004) 1.32
Endoscopic sphincterotomy for bile duct stones in patients 90 years of age and older. Gastrointest Endosc (2000) 1.14
Acute cholangitis. Multivariate analysis of risk factors. Ann Surg (1989) 1.06
Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial. Gastrointest Endosc (2002) 1.02
Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc (2002) 0.98
Acute suppurative obstructive cholangitis due to stones: treatment by urgent endoscopic sphincterotomy. Gastrointest Endosc (1987) 0.88
Reappraisal of safety of endoscopic sphincterotomy for common bile duct stones in the elderly. Am J Surg (1995) 0.84
Endoscopic management of acute calculous cholangitis. J Gastroenterol Hepatol (1997) 0.84
Endoscopic drainage for suppurative cholangitis. Lancet (1989) 0.82
Emergency endoscopic nasobiliary drainage for acute calculous suppurative cholangitis and its potential use in chemical dissolution. J Gastroenterol Hepatol (1993) 0.82
Endoscopic nasobiliary drainage in acute suppurative cholangitis. Indian J Gastroenterol (1994) 0.82
Severe acute cholangitis: the role of emergency nasobiliary drainage. Surgery (1990) 0.81
Emergency endoscopic nasobiliary drainage without the aid of fluoroscopy. Indian J Gastroenterol (1993) 0.81
Does the addition of endoscopic sphincterotomy to stent insertion improve drainage of the bile duct in acute suppurative cholangitis? Gastrointest Endosc (2003) 0.78
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology (2011) 3.45
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology (2008) 3.26
Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B. Am J Gastroenterol (2007) 2.25
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol (2007) 2.11
Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol (2010) 1.66
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2011) 1.64
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2012) 1.62
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol (2005) 1.45
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2011) 1.44
Increased number and function of endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells (SECs) in cirrhosis through paracrine factors. J Hepatol (2012) 1.42
Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol (2003) 1.36
Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology (2011) 1.34
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 1.33
Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases. J Gastroenterol Hepatol (2004) 1.32
Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis (2011) 1.31
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol (2008) 1.27
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol (2006) 1.20
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol (2010) 1.17
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet (2002) 1.11
Endoscopic management of postoperative bile leaks. Hepatobiliary Pancreat Dis Int (2006) 1.10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol (2007) 1.09
Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci (2006) 1.09
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol (2013) 1.08
Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol (2007) 1.08
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Periampullary diverticula and technical success of endoscopic retrograde cholangiopancreatography. Surg Endosc (2008) 1.02
Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol (2004) 1.01
Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol (2006) 0.98
Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology (2012) 0.97
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol (2012) 0.96
Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol (2005) 0.94
Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther (2002) 0.94
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology (2009) 0.92
Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci (2008) 0.92
Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol (2008) 0.91
Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.91
Transient elastographic evaluation in adult subjects without overt liver disease: influence of alanine aminotransferase levels. J Gastroenterol Hepatol (2011) 0.91
Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. J Clin Gastroenterol (2010) 0.91
Primary biliary cirrhosis in India. Hepatobiliary Pancreat Dis Int (2006) 0.91
Management of choledochal cysts and their complications. Am Surg (2012) 0.89
Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). Hepatol Res (2005) 0.89
Management of acute hepatitis B and reactivation of hepatitis B. Liver Int (2013) 0.89
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int (2012) 0.88
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol (2013) 0.88
Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med (2008) 0.88
Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int (2010) 0.88
Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J Med Virol (2003) 0.87
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. Eur J Gastroenterol Hepatol (2010) 0.87
Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol (2011) 0.87
Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience. J Gastroenterol Hepatol (2007) 0.86
Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol (2002) 0.86
CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. World J Gastroenterol (2006) 0.85
Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am J Gastroenterol (2002) 0.85
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int (2014) 0.85
Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells. FEBS J (2015) 0.84
Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene (2013) 0.83
Histological spectrum of chronic hepatitis in precore mutants and wild-type hepatitis B virus infection. Trop Doct (2004) 0.83
Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol (2012) 0.83
Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. J Gastroenterol Hepatol (2011) 0.82
Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol (2009) 0.82
Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J Hepatol (2008) 0.82
Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial. Liver Int (2013) 0.82
Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int (2008) 0.82
Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol (2012) 0.82
Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol (2008) 0.81
Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol (2009) 0.81
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India. Med Microbiol Immunol (2006) 0.81
Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hepatol Int (2007) 0.81
Disaccharides in the treatment of hepatic encephalopathy. Metab Brain Dis (2013) 0.81
Eosinophilic abscesses: a new facet of hepatic visceral larva migrans. Abdom Imaging (2013) 0.81
Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India. Intervirology (2006) 0.80
Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Am J Gastroenterol (2005) 0.80
Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3. J Med Virol (2014) 0.80
Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India. Indian J Pathol Microbiol (2010) 0.79
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients. Gastroenterology (2009) 0.79
Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis (2012) 0.79
Liver regeneration during acute-on-chronic liver failure using growth factors: in vivo or ex vivo indulgence of bone marrow? Gastroenterology (2013) 0.79
Histological profile of liver disease in patients with dual hepatitis B and C virus infection. Indian J Pathol Microbiol (2003) 0.78
Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature. Blood Coagul Fibrinolysis (2013) 0.78
Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatol Int (2014) 0.78
Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology (2010) 0.78
Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients. J Gastroenterol Hepatol (2002) 0.78
Efficacy of Shanvac-B recombinant DNA hepatitis B vaccine in health care workers of Northern India. Hepatobiliary Pancreat Dis Int (2010) 0.78
Antiviral therapy in advanced chronic liver disease due to hepatitis C virus infection: pilot study. J Gastroenterol Hepatol (2005) 0.77
Rifaximin treatment in hepatic encephalopathy. N Engl J Med (2010) 0.77
Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients. Hepatol Int (2008) 0.77
A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein. Hepatobiliary Pancreat Dis Int (2004) 0.77
Randomized controlled trial for endoscopy with propofol versus midazolam on psychometric tests and critical flicker frequency in people with cirrhosis. J Gastroenterol Hepatol (2012) 0.77
Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma. J Vasc Interv Radiol (2013) 0.77
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int (2009) 0.76
Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease. Gastroenterology (2009) 0.75
Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. Diabetes Metab Syndr (2012) 0.75